Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.20
Bid: 134.90
Ask: 135.30
Change: -3.00 (-2.17%)
Spread: 0.40 (0.297%)
Open: 141.50
High: 142.50
Low: 134.80
Prev. Close: 138.20
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.10 Announcement

21 Dec 2015 14:57

21 December 2015

Amlin plc (the “Company”)

Rule 2.10 Announcement

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the “Code”), the Company confirms that, the following number of Shares were transferred from treasury to satisfy the exercise of awards under the Company’s share option schemes.

4,288 ordinary shares at an exercise price of 293.00 pence per share.

867 ordinary shares at an exercise price of 311.00 pence per share.

It had in issue 506,177,051 ordinary shares of 28.125 pence each with ISIN number GB00B2988H17 (“Shares”) in issue as at the date of this announcement.

The total number of Shares attracting voting rights in the Company is 503,352,950.

The above figure may be used by shareholders to determine the percentage of issued share capital they hold in the Company and if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

Contact:

Mark Stevens

Company Secretary

Amlin plc

020 7746 1000

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel’s Market Surveillance Unit on +44 (0)20 7638 0129.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151221005726/en/

Copyright Business Wire 2015

Date   Source Headline
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding
30th May 20238:31 amRNSDirector/PDMR Shareholding
26th May 20239:30 amRNSLTIP and Deferred Bonus Awards
26th May 20239:00 amRNSIssue of Equity and PDMR share awards
26th May 20237:00 amRNSAdmission of New Shares and Total Voting Rights
25th May 20233:05 pmRNSListing Application
18th May 20237:07 amRNSSubstantial Investment in Aston Martin by Geely
17th May 202312:26 pmRNSVoting results of Annual General Meeting
3rd May 20232:37 pmRNSESEF Annual Report
3rd May 20237:00 amRNSQ1 2023 financial results
13th Apr 20239:45 amRNSNotice of AGM
13th Apr 20237:00 amRNSResignation of Non-executive Director
20th Mar 20238:00 amRNSAnnual Financial Report
2nd Mar 20231:01 pmRNSDirector/PDMR Shareholding
1st Mar 20237:00 amRNSFinal Results
23rd Dec 202210:58 amRNSHolding(s) in Company
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20228:30 amRNSHolding(s) in Company
15th Dec 20228:00 amRNSHolding(s) in Company
12th Dec 202212:37 pmRNSHolding(s) in Company
22nd Nov 20229:12 amRNSHolding(s) in Company
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSDirector/PDMR Shareholding
11th Nov 20228:30 amRNSHolding(s) in Company
9th Nov 20223:33 pmRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSDirector/PDMR Shareholding
8th Nov 20228:30 amRNSHolding(s) in Company
3rd Nov 20222:33 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNS3rd Quarter Results
1st Nov 20227:00 amRNSDirectorate Change
10th Oct 20221:55 pmRNSResults and Settlement of Tender Offer
30th Sep 20223:59 pmRNSHolding(s) in Company
30th Sep 20223:57 pmRNSDirector/PDMR Shareholding
30th Sep 20223:52 pmRNSDirector/PDMR Shareholding
30th Sep 20223:43 pmRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20229:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:03 amRNSSuccessful completion of £654m capital raise
30th Sep 20227:00 amRNSHolding(s) in Company
29th Sep 20224:00 pmRNSAppointment of Non-executive Director
29th Sep 20223:05 pmRNSDirector/PDMR Shareholding
29th Sep 20221:36 pmRNSHolding(s) in Company
29th Sep 20228:37 amRNSTender offer for portion of outstanding notes
28th Sep 202212:01 pmRNSRump Placing Announcement
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.